Company: IMXI
Filing Date: 2025-10-21
Form Type: PREM14A
Source: 0001140361-25-038818
Chunk: 64

Company: International Money Express, Inc.
Filing Date: 2025-10-21
Form: PREM14A
Chunk 64
---
 assist the Board of Directors with the strategic process. In light of these discussions, the Board of Directors approved in concept the formation of a special strategic alternatives committee composed entirely of independent and disinterested non-employee directors, Michael Purcell, as Chair, Debra Bradford and Adam Godfrey. On November 7, 2024, the Board of Directors acted by unanimous written consent to formally appoint the Strategic Alternatives Committee based on discussion at the prior day’s meeting, which consent delegated to the Strategic Alternatives Committee all rights, powers and authority of the entire Board of Directors to, among other things, (1) consider whether it is in the best interests of Intermex and its stockholders to proceed with any possible strategic transaction and/or engage in discussions and/or negotiations relating thereto, (2) investigate, negotiate,

<div align='center'>40</div>

#### TABLE OF CONTENTS
review, evaluate and consider any and all possible strategic transactions, (3) reject any possible strategic transactions, (4) recommend to the Board of Directors whether to engage in any possible strategic transaction, (5) consult with and/or advise management, on behalf of the Board of Directors, in connection with discussions and/or negotiations concerning potential terms and conditions of any possible strategic transaction, and (6) interview, select and retain, at Intermex’s expense and on behalf of the Board of Directors and/or the Strategic Alternatives Committee, such additional investment bankers, financial advisors, attorneys, accountants or other advisors and secretarial assistance as it may deem appropriate. In addition, the Board of Directors also instructed directors and management not to solicit from, or negotiate or otherwise engage in any discussions with any bidders (or any bidder’s representatives) regarding their potential post-closing employment, compensation, or equity or other financial participation following or in connection with any possible transaction with any bidder until expressly authorized to do so by the Strategic Alternatives Committee.

On November 8, 2024, Intermex issued a press release announcing its third quarter 2024 earnings results and the commencement of a process to assess strategic alternatives. On November 7, 2024, the trading day immediately prior to such announcement, the closing price for Intermex’s common stock on Nasdaq was $18.50, and on November 11, 2024, the trading day immediately following such announcement, the closing price for Intermex’s common stock on Nasdaq was $21.60.

Following consideration of a number of law firms, the Strategic Alternatives